These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13485556)

  • 1. [Indications & doses of BZ 55 in the treatment of diabetes; contraindications; control of treatment; sulfidemia].
    CABARROU A; CAINO HV; PINTADO OA; BIANCHI NO
    Rev Clin Esp; 1957 Jun; 65(6):399-402. PubMed ID: 13485556
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications and contraindications for oral hypoglycemic drug therapy of diabetes mellitus].
    CAVICCHI E
    Athena; 1958; 24(8-10):131-2. PubMed ID: 13607321
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic trial of minimal doses of carbutamide (BZ 55) in diabetes].
    TOUCEDA AE; VIOLA N; DE ANTONI OA; BASSO G
    Prensa Med Argent; 1958 Jun; 45(23):2168-71. PubMed ID: 13614275
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of diabetes mellitus with oraily administered hypoglycemic agents; BZ-55 or carbutamide and D-860 or tolbutamide].
    JOSELEVICH M; CALVAGNO M; KABANCHIK M
    Prensa Med Argent; 1958 Jan; 45(3):315-8. PubMed ID: 13567427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of D 860 (butyltolylsulfonylcarbamide) & BZ 55 (butylsulfonylcarbamide) in the treatment of diabetes].
    JUTORAN M
    Prensa Med Argent; 1957 Mar; 44(13):985-7. PubMed ID: 13477712
    [No Abstract]   [Full Text] [Related]  

  • 6. [Personal experience with BZ 55 in the treatment of diabetes mellitus].
    CAINO HV; CABARROU A; BIANCHI NO; PINTADO OA
    Rev Clin Esp; 1957 Jul; 66(1):30-5. PubMed ID: 13485567
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical results in the treatment of diabetes mellitus with the preparation BZ 55].
    KULEY M; DEVRIM S; SARACBASI Z; ARPACI N
    Ther Umsch; 1958 Mar; 15(3):58-64. PubMed ID: 13556672
    [No Abstract]   [Full Text] [Related]  

  • 8. [First personal clinical experiences with BZ-55 in treatment of diabetes mellitus].
    PERINOVIC M; OBRADOV S; MUTEVELIC M
    Med Arh; 1958; 12(1):97-107. PubMed ID: 13632325
    [No Abstract]   [Full Text] [Related]  

  • 9. Indications and contraindications for the clinical use of the hypoglycemic sulfonylureas.
    GOLDNER MG; WEISENFELD S
    N Y State J Med; 1958 Mar; 58(5):665-9. PubMed ID: 13517539
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment with peroral antidiabetic drug invenol (BZ-55) and rastinon (D-860) of tuberculotic diabetics].
    KONIGSTEIN RP; SUESS H
    Wien Klin Wochenschr; 1957 Jul; 69(28):501-5. PubMed ID: 13468429
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tests of BZ 55 and D 860 tablets in oral therapy of diabetes mellitus].
    BRAGA M; RODRIGUES DM; DOS SANTOS DM
    Med Contemp; 1958 Apr; 76(4):173-91. PubMed ID: 13551547
    [No Abstract]   [Full Text] [Related]  

  • 12. [BZ 55 in the treatment of diabetes].
    VIEGAS AP
    Rev Bras Med; 1957 Jul; 14(7):467-70. PubMed ID: 13466307
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indications and contraindications for treatment of patients with diabetes mellitus with sulfanilamide preparations].
    GENES SG
    Klin Med (Mosk); 1961 Jun; 39():17-27. PubMed ID: 13704354
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indications and results of oral diabetes treatment].
    Dtsch Med Wochenschr; 1958 Jul; 83(30):1253-68. PubMed ID: 13573900
    [No Abstract]   [Full Text] [Related]  

  • 15. [BZ 55 in psychiatric therapy, a new treatment method].
    LJUNGBERG E
    Sven Lakartidn; 1958 Jun; 55(23):1699-713. PubMed ID: 13569261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of diabetic cardiorespiratory patients with a preparation of oral sulfonylcarbamides (BZ-55 & D-860)].
    ZURITA C
    Rev Esp Tuberc; 1958 Apr; 27(277):169-75. PubMed ID: 13555122
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical investigation of hypoglycemic effect of seeds of Azadirachta-inidca in type-2 (NIDDM) diabetes mellitus.
    Waheed A; Miana GA; Ahmad SI
    Pak J Pharm Sci; 2006 Oct; 19(4):322-5. PubMed ID: 17105712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes, psoriasis and thiazolidinediones.
    Krentz AJ; Friedmann PS
    Int J Clin Pract; 2006 Mar; 60(3):362-3. PubMed ID: 16494655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of stroke in patients with and without diabetes--similarity and differences].
    Zalisz M
    Pol Merkur Lekarski; 2007 Oct; 23(136):291-6. PubMed ID: 18293854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes. VII. Indications & practical application of sulfonamide antidiabetics].
    LEBOUC R
    Concours Med; 1959 May; 81(19):2217-8 passim. PubMed ID: 13652529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.